An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Lymphoma

Update Il y a 4 ans
Reference: NCT01609036

Woman and Man

  • | Country :
  • Greece
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This observational study will evaluate the safety and efficacy of MabThera/Rituxan (rituximab) in previously untreated patients with follicular lymphoma. Data will be collected for 3 years


Inclusion criteria

  • Lymphoma, Follicular

Links